Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116004955> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2116004955 endingPage "42" @default.
- W2116004955 startingPage "37" @default.
- W2116004955 abstract "The major cause of chronic liver disease, cirrhosis, liver carcinoma and liver failure is Hepatitis C virus (HCV). NS3 is one of the attractive targets for therapy development for HCV as the N-terminal domain of the NS3 protein is a serine protein. NS3 protease acts by interfering with cellular mechanisms which are involved in the host immune response to an HCV infection and the inhibition of the protease is an efficient antiviral approach. NS3 protease inhibitors initially developed were: BILN 2061 (Ciluprevir), VX-950 (Telaprevir) and SCH503034. A combination therapy of injected pegylated interferon-α and oral ribavirin is regarded as the current standard therapy for HCV infection. Leucopenia, flu-like symptoms, thrombocytopenia, depression and anemia are some of the adverse effects of ribavirin. The compounds which constitute a benzoxaborole moiety interact with many biological targets and presents appreciable qualities. The acyl sulfinamide and the acyl cyanamide were shown to be potent P1 C-terminal groups in the enzyme assay. In a study, it is indicated that the aminobenzoyl sulfonamide fragment was identified as a novel P1 structural motif. New P2–P4 macrocycle inhibitors of NS3/4A were made up of a P1 C-terminal carboxylic acid have recently been developed. Potent tetrapeptidic inhibitors of the HCV NS3 protease have been developed by incorporating 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a new N-acyl-L-hydroxyproline were developed for the treatment of Hepatitis C. α-Amino cyclic boronates was designed and synthesized and incorporated successfully in several acyclic templates at the P1 position as HCV inhibitors. The boronic acid compounds acts as the HCV NS3 serine protease inhibitors. Some of the HCV-protease inhibitors are developed which are based on a 2(1H)-pyrazinone P3 scaffold in combination with either a P2 phenylglycine or a glycine. NS3/4A protease inhibitors constituting of quinazoline derivatives as P2 substituent were synthesized. The tripeptide-based inhibitors of the HCV NS3 protease containing a novel P2-triazole had been synthesized. A protease domain (NS3pro) and RNA helicase domain (NS3hel) makes a multifunctional enzyme: Flaviviridae non-structural 3 proteins (NS3). Crude ethanol extract from rhizomes of the Chinese medicinal herb Rhodiola kirilowii (Regel) Maxim was also used for the cure of Hepatitis C. A new series of HCV NS3/4A protease inhibitors bearing a P2-P4 macrocycle and a P1- P10 a-ketoamide serine trap has been studied.Key words: Hepatitis C virus, non-structural protein inhibitors." @default.
- W2116004955 created "2016-06-24" @default.
- W2116004955 creator A5025819064 @default.
- W2116004955 creator A5052966888 @default.
- W2116004955 creator A5066015848 @default.
- W2116004955 date "2015-01-22" @default.
- W2116004955 modified "2023-09-23" @default.
- W2116004955 title "A review on novel therapies to combat hepatitis C" @default.
- W2116004955 cites W1971351365 @default.
- W2116004955 cites W1977935857 @default.
- W2116004955 cites W1981073634 @default.
- W2116004955 cites W1995107778 @default.
- W2116004955 cites W1999767209 @default.
- W2116004955 cites W2002608073 @default.
- W2116004955 cites W2014492593 @default.
- W2116004955 cites W2034206570 @default.
- W2116004955 cites W2060399390 @default.
- W2116004955 cites W2067045621 @default.
- W2116004955 cites W2067291997 @default.
- W2116004955 cites W2071468505 @default.
- W2116004955 cites W2072029488 @default.
- W2116004955 cites W2078125666 @default.
- W2116004955 cites W2145130602 @default.
- W2116004955 cites W2147082962 @default.
- W2116004955 doi "https://doi.org/10.5897/ajpp2012." @default.
- W2116004955 hasPublicationYear "2015" @default.
- W2116004955 type Work @default.
- W2116004955 sameAs 2116004955 @default.
- W2116004955 citedByCount "1" @default.
- W2116004955 countsByYear W21160049552018 @default.
- W2116004955 crossrefType "journal-article" @default.
- W2116004955 hasAuthorship W2116004955A5025819064 @default.
- W2116004955 hasAuthorship W2116004955A5052966888 @default.
- W2116004955 hasAuthorship W2116004955A5066015848 @default.
- W2116004955 hasConcept C132379496 @default.
- W2116004955 hasConcept C159047783 @default.
- W2116004955 hasConcept C181199279 @default.
- W2116004955 hasConcept C185592680 @default.
- W2116004955 hasConcept C2522874641 @default.
- W2116004955 hasConcept C2776408679 @default.
- W2116004955 hasConcept C2776455275 @default.
- W2116004955 hasConcept C2776714187 @default.
- W2116004955 hasConcept C2777807008 @default.
- W2116004955 hasConcept C2780040827 @default.
- W2116004955 hasConcept C55493867 @default.
- W2116004955 hasConcept C71924100 @default.
- W2116004955 hasConcept C98274493 @default.
- W2116004955 hasConceptScore W2116004955C132379496 @default.
- W2116004955 hasConceptScore W2116004955C159047783 @default.
- W2116004955 hasConceptScore W2116004955C181199279 @default.
- W2116004955 hasConceptScore W2116004955C185592680 @default.
- W2116004955 hasConceptScore W2116004955C2522874641 @default.
- W2116004955 hasConceptScore W2116004955C2776408679 @default.
- W2116004955 hasConceptScore W2116004955C2776455275 @default.
- W2116004955 hasConceptScore W2116004955C2776714187 @default.
- W2116004955 hasConceptScore W2116004955C2777807008 @default.
- W2116004955 hasConceptScore W2116004955C2780040827 @default.
- W2116004955 hasConceptScore W2116004955C55493867 @default.
- W2116004955 hasConceptScore W2116004955C71924100 @default.
- W2116004955 hasConceptScore W2116004955C98274493 @default.
- W2116004955 hasIssue "3" @default.
- W2116004955 hasLocation W21160049551 @default.
- W2116004955 hasOpenAccess W2116004955 @default.
- W2116004955 hasPrimaryLocation W21160049551 @default.
- W2116004955 hasRelatedWork W1539968449 @default.
- W2116004955 hasRelatedWork W1966522777 @default.
- W2116004955 hasRelatedWork W1991470366 @default.
- W2116004955 hasRelatedWork W2012503063 @default.
- W2116004955 hasRelatedWork W2013411037 @default.
- W2116004955 hasRelatedWork W2014299974 @default.
- W2116004955 hasRelatedWork W2033058866 @default.
- W2116004955 hasRelatedWork W2070587341 @default.
- W2116004955 hasRelatedWork W2605705609 @default.
- W2116004955 hasRelatedWork W2725446377 @default.
- W2116004955 hasRelatedWork W2791847684 @default.
- W2116004955 hasRelatedWork W2799742983 @default.
- W2116004955 hasRelatedWork W2888397148 @default.
- W2116004955 hasRelatedWork W2904762682 @default.
- W2116004955 hasRelatedWork W3042867880 @default.
- W2116004955 hasRelatedWork W993588088 @default.
- W2116004955 hasRelatedWork W2814026731 @default.
- W2116004955 hasRelatedWork W2859858969 @default.
- W2116004955 hasRelatedWork W2877817144 @default.
- W2116004955 hasRelatedWork W3102861130 @default.
- W2116004955 hasVolume "9" @default.
- W2116004955 isParatext "false" @default.
- W2116004955 isRetracted "false" @default.
- W2116004955 magId "2116004955" @default.
- W2116004955 workType "article" @default.